Research article Open access
Cushing’s Disease: Sustained remission in five cases induced by medical therapy with the dopamine agonist cabergoline
We report five cases of Cushing’s disease where the patients were given a therapeutic trial of cabergoline. Morning serum cortisol, adrenocorticotrophic hormone (ACTH), and sleeping cortisol concentrations were significantly raised. Magnetic resonance imaging (MRI) scans revealed pituitary microadenomas in 3 patients b …